KEY FEATURES
| Full Name | Platelet/Endothelial Cell Adhesion Molecule |
|---|---|
| Synonym | CD31; EndoCAM; GPIIA'; PECA1 |
| Assay Type | Sandwich |
| Reactivity | Human |
| Range | 31.2-2000pg/mL |
| Sensitivity | 12.2pg/mL |
| Sample Type | Serum,plasma and other biological fluids |
| Sample Volume | 100μL |
| Detection Wavelength | OD450 |
| Transportation Temperature | 2-8°C |
| Specificity | The kit detected Human PECAM1 in the samples and no significant cross-species reactions were found |
| Microplate | 96-wells plate breakable into 12 x 8 wells strip |
TEST PRINCIPLE
| This ELISA kit uses the Sandwich-ELISA principle. The micro ELISA plate provided in this kit has been pre-coated with an antibody specific to Human PECAM1. Standards or samples are added to the micro ELISA plate wells and combined with the specific antibody. Then a biotinylated detection antibody specific for Human PECAM1 and Avidin-Horseradish Peroxidase (HRP) conjugate are added successively to each micro plate well and incubated. Free components are washed away. The substrate solution is added to each well. Only those wells that contain Human PECAM1, biotinylated detection antibody and Avidin-HRP conjugate will appear blue in color. The enzyme-substrate reaction is terminated by the addition of stop solution and the color turns yellow. The optical density (OD) is measured spectrophotometrically at a wavelength of 450 nm ± 2 nm. The OD value is proportional to the concentration of Human PECAM1. You can calculate the concentration of Human PECAM1 in the samples by comparing the OD of the samples to the standard curve. |
ELISA KIT COMPONENTS
Upon receipt, unpack promptly and store as recommended in the instructions.
| Components | Specifications | Storage and Notes |
|---|---|---|
| Micro Plate | 96T: 8 wells×12 strips 48T: 8 wells×6 strips | Unopened: -20°C, 12 months Unused: Put it back in the aluminum foil bag and seal it, store it at -20°C. |
| Reference Standard | 96T: 2 vials 48T: 1 vial | Unopened: -20°C, 12 months Please use freshly dissolved standards for each experiment. Discard any unused standards after dissolution. |
| Biotinylated Detection Ab Concentrate (100×) | 96T: 120μL×1 vial 48T: 60μL×1 vial | Unopened: -20°C, 12 months Unused: Please seal the concentrate and store it at -20°C, and discard the working solution. |
| HRP Conjugate Concentrate (100×) | 96T: 120μL×1 vial 48T: 60μL×1 vial | Unopened: -20°C(Protect from light), 12 months Unused: Please seal the concentrate and store it at -20°C, and discard the working solution. |
| Biotinylated Detection Ab Diluent | 14mL×1 | 2-8℃, 12 months |
| HRP Conjugate Diluent | 14mL×1 | 2-8℃, 12 months |
| Reference Standard & Sample Diluent | 20mL×1 | 2-8℃, 12 months |
| Washing Buffer Concentrate (25×) | 30mL×1 | 2-8℃, 12 months |
| Substrate Reagent(TMB) | 10mL×1 | 2-8°C(Protect from light),12 months |
| Stop Solution | 7mL×1 | 2-8°C/Room temperature |
ASSAY PROCEDURES

TYPICAL DATA

Human PECAM1 ELISA Standard Curve
Typical data are for reference only and curves should be replotted for each experiment. The Logistics function is recommended for fitting.
PRECISION
Intra-Assay Precision (Precision within an assay): Three samples of known concentration were tested twenty times on one plate to assess intra-assay precision.
Inter-Assay Precision (Precision between assays): Three samples of known concentration were tested in twenty separate assays to assess inter-assay precision. Assays were performed by at least three technicians using two lots of components.
| Intra-assay Precision | Inter-assay Precision | |||||
|---|---|---|---|---|---|---|
| Sample | 1 | 2 | 3 | 1 | 2 | 3 |
| n | 20 | 20 | 20 | 20 | 20 | 20 |
| Mean (pg/mL) | 100.45 | 305 | 756.82 | 94.12 | 309.93 | 710.99 |
| Standard deviation | 5.23 | 17.14 | 33.68 | 6 | 17.23 | 27.73 |
| CV(%) | 5.21 | 5.62 | 4.45 | 6.38 | 5.56 | 3.9 |
RECOVERY
The recovery of Human PECAM1 spiked to three different levels in samples throughout the range of the assay in various matrices was evaluated.
| Sample Type | Range (%) | Average Recovery (%) |
|---|---|---|
| Serum(n=8) | 84-98 | 90 |
| EDTA plasma (n=8) | 93-109 | 100 |
| Cell culture media (n=8) | 85-97 | 92 |
LINEARITY
To assess the linearity of the assay, samples containing and/or spiked with high concentrations of Human PECAM1 in various matrices were diluted with the Reference Standard & Sample Diluent to produce samples with values within the dynamic range of the assay.

Products associated with CD31 ELISA Kits
| CD38 antibody | publications with CD31 and CD38 |
| SRC antibody | publications with CD31 and SRC |
| CTNNB1 antibody | publications with CD31 and CTNNB1 |
| PTPN11 antibody | publications with CD31 and PTPN11 |
| PTPN6 antibody | publications with CD31 and PTPN6 |
| CSK antibody | publications with CD31 and CSK |
| FYN antibody | publications with CD31 and FYN |
| ITGB3 antibody | publications with CD31 and ITGB3 |
| LYN antibody | publications with CD31 and LYN |
| JUP antibody | publications with CD31 and JUP |
Pathways associated with CD31 ELISA Kit
| Cell Adhesion Molecules (CAMs) Pathway | Cell Adhesion Molecules (CAMs) Pathway |
| Cell Surface Interactions At The Vascular Wall Pathway | Cell Surface Interactions At The Vascular Wall Pathway |
| Hemostasis Pathway | Hemostasis Pathway |
| Integrin Cell Surface Interactions Pathway | Integrin Cell Surface Interactions Pathway |
| Leukocyte Transendothelial Migration Pathway | Leukocyte Transendothelial Migration Pathway |
| Malaria Pathway | Malaria Pathway |
| PECAM1 Interactions Pathway | PECAM1 Interactions Pathway |
Diseases associated with CD31 ELISA Kit
| Neoplasms | publications with CD31 and Neoplasms |
| Inflammation | publications with CD31 and Inflammation |
| Necrosis | publications with CD31 and Necrosis |
| Neoplasms, Experimental | publications with CD31 and Neoplasms, Experimental |
| Neoplasm Metastasis | publications with CD31 and Neoplasm Metastasis |
| Lung Diseases | publications with CD31 and Lung Diseases |
| Heart Diseases | publications with CD31 and Heart Diseases |
| Breast Neoplasms | publications with CD31 and Breast Neoplasms |
| Lung Neoplasms | publications with CD31 and Lung Neoplasms |
| Liver Diseases | publications with CD31 and Liver Diseases |
Organs/Tissues associated with CD31 ELISA Kit
| Vascular | publications with CD31 and Vascular |
| Blood | publications with CD31 and Blood |
| Muscle | publications with CD31 and Muscle |
| Bone Marrow | publications with CD31 and Bone Marrow |
| Lung | publications with CD31 and Lung |
| Heart | publications with CD31 and Heart |
| Brain | publications with CD31 and Brain |
| Liver | publications with CD31 and Liver |
| Umbilical Cord | publications with CD31 and Umbilical Cord |
| Kidney | publications with CD31 and Kidney |